Anti-proliferative effects of (–)-isostemonamine on highly aggressive human breast cancer MDA-MB-231 cells

DOI Web Site 被引用文献2件 参考文献4件 オープンアクセス
  • Hirao-Suzuki Masayo
    Laboratory of Xenobiotic Metabolism and Environmental Toxicology, Faculty of Pharmaceutical Sciences, Hiroshima International University (HIU)
  • Takeda Shuso
    Laboratory of Xenobiotic Metabolism and Environmental Toxicology, Faculty of Pharmaceutical Sciences, Hiroshima International University (HIU)
  • Iwata Takayuki
    Institute for Materials Chemistry and Engineering, Kyushu University
  • Fujita Satoshi
    Institute for Materials Chemistry and Engineering, Kyushu University
  • Tomiyama Taishi
    Institute for Materials Chemistry and Engineering, Kyushu University
  • Takiguchi Masufumi
    Laboratory of Xenobiotic Metabolism and Environmental Toxicology, Faculty of Pharmaceutical Sciences, Hiroshima International University (HIU)
  • Shindo Mitsuru
    Institute for Materials Chemistry and Engineering, Kyushu University

この論文をさがす

説明

<p>Stemona alkaloids such as (±)-stemonamine/ (±)-isostemonamine, have a unique structure, possibly coupled with potential biological activities. The establishment of effective total synthesis protocols for stemonamine alkaloids has been a challenge for synthetic chemists so far. These stemonamine alkaloids are isolated as racemates and there is no report concerning their asymmetric total synthesis. It is generally understood that any pair of enantiomers have physically and chemically indistinguishable properties. However, stereochemistry is a critical point in biological systems because most biological reactions, such as those mediated by enzymes and receptors, are stereospecific. We have successfully established the methods of asymmetric total synthesis of the stemonamine alkaloids, (–)-stemonamine/(–)-isostemonamine. We studied the potential application of these Stemona alkaloids as anti-proliferative agents. Experiments were conducted by using two representative human breast cancer cell lines, MCF-7 and MDA-MB-231, and our results indicated that i) (–)-isostemonamine displays strong cytotoxic effects on the highly aggressive estrogen receptor α (ERα)-negative MDA-MB-231 cell line, but not on the ERα-positive MCF-7 cells, with an IC50 value (9.3 ± 1.9 μM), which is comparable to that of etoposide (IC50 = 7.1 μM ± 1.4 μM), and ii) the thioamide derivative of (–)-isostemonamine does not suppress the growth of MDA-MB-231 cells.</p>

収録刊行物

  • BPB Reports

    BPB Reports 1 (2), 32-34, 2018

    公益社団法人 日本薬学会

被引用文献 (2)*注記

もっと見る

参考文献 (4)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ